We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
South Korea’s quickly growing biologics CDMO, Samsung BioLogics, has won FDA approval for its first finished product at the second of three plants that have been built in rapid succession.